Cite
HARVARD Citation
Mudigonda, T. et al. (n.d.). A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma. Pigment cell & melanoma research. pp. 101-103. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mudigonda, T. et al. (n.d.). A phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma. Pigment cell & melanoma research. pp. 101-103. [Online].